NASDAQ: CMECme Group Inc Stock
$208.26-2.54 (-1.2%)
Updated May 15, 2024
CME Price
$208.26
Fair Value Price
$196.75
Market Cap
$74.99B
52 Week Low
$175.73
52 Week High
$223.80
P/E
23.69x
P/B
2.76x
P/S
13.75x
PEG
6.42x
Dividend Yield
4.66%
Revenue
$5.63B
Earnings
$3.20B
Gross Margin
100%
Operating Margin
75.9%
Profit Margin
56.1%
Debt to Equity
3.86
Operating Cash Flow
$3B
Beta
0.76
Next Earnings
N/A
Ex-Dividend
Jun 7, 2024
Next Dividend
Jun 25, 2024
CME Overview
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Zen Score
–
Industry Average (37)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CME scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CME ($208.26) is overvalued by 5.85% relative to our estimate of its Fair Value price of $196.75 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CME ($208.26) is not significantly undervalued (5.85%) relative to our estimate of its Fair Value price of $196.75 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CME ($208.26) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CME due diligence checks available for Premium users.
Be the first to know about important CME news, forecast changes, insider trades & much more!
CME News
Valuation
CME fair value
Fair Value of CME stock based on Discounted Cash Flow (DCF)
Price
$208.26
Fair Value
$196.75
Overvalued by
5.85%
CME ($208.26) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CME ($208.26) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CME ($208.26) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CME price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.69x
Industry
36.56x
Market
31.36x
CME is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CME is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CME price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.76x
Industry
4.55x
CME is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CME price to earnings growth (PEG)
For valuing profitable companies with growth potential
CME is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CME's financial health
Profit margin
Revenue
$1.5B
Net Income
$844.4M
Profit Margin
56.8%
CME's Earnings (EBIT) of $4.27B... subscribe to Premium to read more.
Interest Coverage Financials
CME's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$132.1B
Liabilities
$104.9B
Debt to equity
3.86
CME's short-term assets ($97.31B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CME's short-term assets ($97.31B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CME's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CME's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$892.7M
Investing
-$22.8M
Financing
$1.9B
CME's operating cash flow ($3.44B)... subscribe to Premium to read more.
Debt Coverage Financials
CME vs Financial Datum & Stock Exchange Stocks
Cme Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.